Landos Biopharma, Inc. - LABP
About Gravity Analytica
Recent News
- 09.09.2025 - BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories
- 09.05.2025 - AbbVie Declares Quarterly Dividend
- 09.03.2025 - AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
- 09.03.2025 - Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
- 09.02.2025 - AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
- 08.25.2025 - AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
- 08.21.2025 - AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
- 08.19.2025 - AbbVie Completes Acquisition of Capstan Therapeutics
- 08.19.2025 - SkinMedica® Unveils Its Newest Hydration Hero
- 08.12.2025 - AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.